chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist refers to a patient of unknown age. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23 (lot # H015749, expiry date 08-JUN-2014). The patient was also vaccinated with a dose of DTaP (manufacturer unknown) and AFLURIA on the same day. On an unknown date, the patient experienced severe nasal congestion, chills, arm swelling and loss of appetite. The outcome of severe nasal congestion, chills, arm swelling and loss of appetite was reported as not recovered The patient sought medical attention. This is one of the two reports received from the same reporter. Additional information has been requested.
Onset of left-side facial drooping (mimicking Stroke symptoms; 54 hours after injection
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medications, medical history and drug reactions was not provided. On 21-MAR-2006, the patient was vaccinated with a first dose of VAQTA (lot # and expiration date were not reported) orally for prophylaxis at 2 years of age. On 19-SEP-2006, the patient received a second dose of VAQTA hepatitis which was 2 days early (Inappropriate schedule of vaccine administered). No adverse effects were reported.
Kinrix instead of Infanrix; Kinrix given to pt; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 18-month-old male patient who received DTPa-IPV (Kinrix) (batch number 7p5j5, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th June 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 28th June 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received Kinrix instead of Infanrix at the age of 18 months, which led to wrong vaccine administered and inappropriate age at vaccine administration.  No adverse event was reported. The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter. This case had been linked with case US2022025617, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022025617:Same reporter.
other symptoms; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (other symptoms) and MYALGIA (arm soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (other symptoms) and MYALGIA (arm soreness). At the time of the report, VACCINATION COMPLICATION (other symptoms) and MYALGIA (arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided treatment information was not provided
The mother stated the child complained of feeling hot, became flushed and diaphoretic, and consequently vomited.  After vomiting, the pt was pale.  Blood pressure after incident 85/52 and BP 30 later was 98/58
Initial case received from a consumer, who is also the patient's parent, on 13 October 2009. A six-year-old male patient experienced blurry vision, dizziness, a rash, hives, and itching after receiving intramuscular deltoid injection of FLUZONE (lot number not reported) on 07 October 2009. The patient had no relevant medical history, and no known allergies. Approximately 48 hours post-vaccination, the patient developed a red rash on his upper body, hives, itching, blurry vision, and dizziness. He was taken to the emergency department that day, and was treated with prednisone. On 12 October 2009, he was seen by an allergist, and additional treatment included BENADRYL, ZYRTEC, and PEPCID. At the time of the report, the itching and redness was ongoing. Additional information was received on 19 October 2009 from a health care professional. According to the reporter, the patient developed generalized hives, rash and itching two days after he had received FLUZONE No Preservative (previously reported as FLUZONE SV); the lot number was reported as unknown. The patient went to the emergency room and received steroids, BENADRYL and ZYRTEC with some relief. At the time of the report, the patient had been seeing an allergist. It was further noted that the patient had developed hives after receiving Hepatitis vaccine when he was five years of age. No additional information was provided at the time of the report. Documents held by sender: None.
Pfizer 2/6/21, 2/27/21. Positive on 6/27/22
Woke up feeling extremely sad and depressed. Fatigued. No energy. Not sure if this is related but it has lasted a week and I?ve never in my life felt this. I also developed strong headache in the back of head and neck and felt mental cloudiness. Unsure if related but tested negative to COVID 2 times this week.
Was told by coworkers face looked red after vaccination, then itchy red raised rash on forearms; resolved next day; pt stated used Benadryl cream.
Mother states temp 103 , fussy, phone call to physician - not seen per physician. Administered Advil : pm of injection.
At the end of May I began having chest pain. At first I thought it was a sore muscle, but it got worse, not better. It got bad enough to go the the ER June 11. They discharged me after doing labs and an x-ray as they ruled out a heart attack. I then went to a cardiologist June 22nd and he looked over my labs and said I wasn?t having a heart attack. He sent me off without any other tests not sure what was causing the pain. It began subsiding around July 15th, but I still have pain every now and then.
Hospitalization same day as Pfizer COVID-19 Vaccine (4/8/21) post-syncopal episode, hypotensive, CHF exacerbation and sepsis. Diagnosed: pyelonephritis and E.coli bacteremia, given abx coverage. 4/11 nephrostomy tube placed. 4/20 pt stable to disch to LTAC.
I received the vaccine while pregnant. My son was born 4/9/21 at 10:45 pm. At 7 pounds 7.8 ounces. He got circumcised and had bleeding issues. Then over the course of the next few months he was having issues where he bruised really easily.  Took him to his pediatrician and she the referred him to a hematologist who confirmed he has a mild platelet disorder-unsure of which one as he is too young to do further testing. My family has no history of bleeding disorders that I?m aware of.
large red patch on left arm, about 2.5 inches across.  slightly raised, reddened area looks chapped.  warm to touch.  a little sore.   I just noticed it today and don't really know when it started, but i know for sure it was not within the first 3 or 4 days after injection because at that time i was checking my arm daily.   As of now i have not seen a doctor as i read news reports that this is not a rare or harmful occurrence.
I requested flu shot. Given at  9am Oct 27 2005. Before noon, I had excruciating pain all over head. I have had head pain (chronic) over the late years, but this just added a great deal of pain. Phones Dr office. on Mon Oct 31, saw Dr he added medication I was already taking.
Headache, dizziness, nausea, chills, chest pain, fatigue, injection site pain. Started about 2 hours after injection. Took Tylenol.  Symptoms resolved within 36 hours
Information has been received from a licensed practical nurse concerning a 66 year old female with hypothyroidism and osteoarthritis and no allergies who on 22-SEP-2010 was vaccinated with a dose of 0.5 ml of PNEUMOVAX 23 (lot # 667136/0499Z, expire date 25-NOV-2011) intramuscularly. Concomitant therapy included NEURONTIN, CARDIZEM, LEVOXYL, IMITREX, calcium (unspecified) (+) vitamin D (unspecified) and PROZAC. On 23-SEP-2010 it was reported that patient awoke with pain, redness and induration of right deltoid and was treated with TYLENOL and ice packs. The patient was insured if she had received the vaccine in the past but the office had no record of previous vaccination. At the time of the report the patient was recovering. The patient sought unspecified medical attention. There were no laboratories diagnostics studies performed. Additional information has been requested.
PATIENT PASSED OUT MOMENTARILY FOR NO MORE THAN 30 SECONDS WITHIN 5 MINUTES OF RECEIVING VACCINE DOSE. PATIENT SELF-REPORTED FEELING ONSET RIGHT BEFORE SYNCOPE OCCURRED. HE SLUMPED BACK IN HIS CHAIR (DID NOT FALL) AND ARMS DROPPED TO HIS SIDES. DURING SYNCOPE PATIENT HAD SHALLOW AND QUICK BREATHING AND TURNED PALE FOR ABOUT 15-20 SECONDS. BREATHING THEN NORMALIZED FOR 10 SECONDS AND PATIENT REGAINED SOME COLOR TO COMPLEXION. PATIENT FINALLY WOKE UP FEELING SLIGHTLY NAUSEOUS, DIAPHORETIC, AND STILL SLIGHTLY PALE. HE WAS PROVIDED WATER AND A GLUCOSE TABLET AND VITALS WERE TAKEN. HE DECLINED PARAMEDICS OR ANY EMERGENCY ASSISTANCE, AND LEFT THE FACILITY ON HIS OWN.
Sunday 2/28/2021 around 6:00 pm I notice a 2cm diameter red know at injection site that had fever and 3 in down from that was another knot that was itching. Monday 3/2/2021 the site has grown and is 5-6 cm in diameter, red/purple in color, and has fever.
Headache, Myalgia, NauseaVomiting, 1st - site soreness, HA, stiff neck 2 days. 2nd dose- soreness, red  and swelling at site 4 days, HA, stiff neck, fatigue, body aches, nausea 4 days  Narrative:  Other Relevant History:
Information has been received from a health professional concerning a 15 year old male who had already vaccinated with two doses of MMR II, 0.5ml subcutaneously injection prior to receiving a dose of PROQUAD (Merck) on 04-APR-2011 when the patient was given a dose of PROQUAD (Merck) instead of a dose of VARIVAX (Merck). Healthcare worker did not know the dates of administration of the two doses of MMR II. It was unknown if the patient sought medical attention. No adverse effects reported. Additional information has been requested.
Chills; body aches; fatigue; headache; nausea; lack of appetite; trouble sleeping; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 66-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ELO 142 and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 03Feb2021 at 10:30 as DOSE 1 (age at vaccination: 66-years-old, SINGLE for covid-19 immunisation. Medical history included colitis ulcerative, tachycardia (tackacardia) and seborrhoea. Concomitant medication included metoprolol tartrate (LOPRESSOR). There was no Allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced chills, body aches, fatigue, headache, nausea, lack of appetite and trouble sleeping on 03Feb2021 at 15:00. No treatment was received for the adverse events. Outcome of all the events was recovering.   Follow-up attempts are completed. No further information is expected.
2 to 3 mins p/vax noted to have approx 3 cm wheal @ site of inject; about 5 mins later noted to have approx 10 cm of swelling & redness surrounding site; no signs of systemic react;
Tiredness, nausea, vomiting, diarrhea, chills, dizziness
Unilateral axillary lymphadenopathy; This is a spontaneous report from a contactable physician, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 02Sep2021 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04Aug2021, the patient underwent polymerase chain reaction (PCR) test via nasal swab and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone propionate (FLONASE) and unspecified oral contraceptive pill (OCP); both for unknown indications from unknown dates and unknown if ongoing. On 03Sep2021 at 15:00, the patient experienced unilateral axillary lymphadenopathy. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19 (reported as yes). Therapeutic measures were not taken as a result of the event. The clinical outcome of the event unilateral axillary lymphadenopathy was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
neck pain; stiffness; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent.  A 14 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: FA7485) at the age of 14 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: NECK PAIN (non-serious) with onset 01Aug2021, outcome "not recovered", described as "neck pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 01Aug2021, outcome "not recovered", described as "stiffness". Therapeutic measures were taken as a result of neck pain, musculoskeletal stiffness. Additional Information: The caller stated that the patient started experiencing neck pain and stiffness, worsening today. He says he would like to know have any other children reported this type of symptom. Caller says that their son has been taking Motrin and he says his pain and stiffness are worse tonight than this morning, it is on the left side of his neck, the same side as he got his shot.  No follow-up attempts are possible. No further information is expected.
No additional AE; Caller reporter improperly stored and administered vaccines for MMR-II, PROQUAD, and VARIVAX to multiple patients since May 2023 (TE occurred 5/9/2023). No symptoms reported. Caller did not have specific AE information available regarding patient inf; This spontaneous report was received from Other and refers to a 7-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 07-JUN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W020540, expiration date: 28-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided). This vaccine underwent temperature excursion before administration in 58.65 degree Farenheit (F) for 25 hours 45 minutes (Product storage error). No additional adverse event was reported.
Fever 102.5 with seizures. Took to Hospital ER. Dr. said it was due to fever-febrile seizures. Dr. told mother to continue Tylenol and Motrin for fever.
Family member visited on Thursday, March 4th, 2010 and c/o that his entire family including the above client has had chest congestion, runny nose, aches, on and off fever since receiving H1N1 vaccine. Client has not been seen by a physician for these signs and symptoms.
Profuse and protracted vomiting, severe chills with muscle spasms, diarrhea, headache
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date during 2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On an unspecified date during 2016, the patient was treated for a blistering vesicular outbreak which was then diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
1/1/22 Pt is a 82 yr/o female who was brought in by medical personnel after she was found down at her nursing facility   o She was hypotensive at the scene and on route here. o O2 sat 93% on room air. o Patient initially totally unresponsive, would not wake to voice or pain, then eventually started moving around slightly, but does not follow instruction. o Unknown if the patient had been having any symptoms of illness prior to today.    o Reviewing the paperwork sent with her, she does have a history of hypothyroidism, adrenal insufficiency. o On hydralazine for BP. o History also notable for metabolic encephalopathy.    Physical Exam    Appearance: She is well-developed. She is not diaphoretic.     Comments: Thin, chronically ill-appearing.  HENT:     Head: Normocephalic.     Mouth/Throat:     Mouth: Mucous membranes are dry.  Eyes:     General: No scleral icterus.    Conjunctiva/sclera: Conjunctivae normal.     Pupils: Pupils are equal, round, and reactive to light.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds.     Comments: 93 % RA Abdominal:     General: There is no distension.     Palpations: Abdomen is soft.     Tenderness: There is abdominal tenderness (winces w palpation).  Musculoskeletal:        General: No tenderness. Normal range of motion.     Cervical back: Neck supple.     Comments: Swelling left lower extremity, healed surgical scar with surrounding hyperpigmentation.  Skin:    General: Skin is warm and dry.  Neurological:     Mental Status: She is lethargic.     Comments: Frowning, does not respond to commands, withdraws to pain. No obvious unilateral deficit.
blood pressure high compared to normal; heart pounding faster than usual; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual). At the time of the report, HYPERTENSION (blood pressure high compared to normal) and HEART RATE INCREASED (heart pounding faster than usual) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Blood pressure measurement: 160/88 mmHg (High) 160/88. On 10-Mar-2021, Heart rate: 93 beats per minute (High) 93. In March 2021, Blood pressure measurement: 142/87 mmHg (Inconclusive) 142/87.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication includes antidepressant medications and sleeping medications.  Treatment information was not provided.
Information has been received from an 18 year old female certified medical assistant, who was vaccinated with her first dose of Gardasil. Subsequently she started getting her menstrual period every two weeks for about a month and a half. Additional information has been requested. This is one of two reports from the same source.
my son woke up in the morning for school and said he felt sick to his stomach. He stood up and immediately ran to the bathroom to throw up. This happened 3 times within a 45 minute period. After that he had severe diarrhea for the remainder of the day from 11am and on. He had to change his clothes 4 times and spent hours on the toilet. My son has a strong immune system and rarely gets sick. He will not be getting the 2nd vaccine. After this happened he slept for several hours and woke up 4 hours later and felt perfectly fine.
The day following second dose of Moderna -  started experiencing inability to grip, numbness, dryness and swelling as well as soreness and tingling.  Specifically reports both hands feeling like she has a "boxing mitt" on each hand but there is nothing there. Also not able to write with right hand without feeling like her hands are numb and misses some writing.     PCP prescribed AV cream and instructed her to stay out of water.  Scheduled to see dermatologist in August 2022.  Dr. is her dermatologist.
Became dizzy and light headed one hour after dose.  Unable to walk.  Then began having tingling/burning feeling over entire body.
PATIENT CAME IN FOR HIS SECOND DOSE OF MODERNA AND TECHNICIAN GAVE PATIENT PFIZER -BioNTech  INSTEAD
This spontaneous report as received from a nurse refers to a 14 year old female patient with no pertinent medical history allergies. On 20-MAY-2013 the patient was vaccinated with GARDASIL dose 1, intramuscular in the right arm. Concomitant medication were reported as none. On 20-MAY-2013, the patient experienced black bruised mark on the right arm where she received the vaccine. Ten days later, on 30-MAY-2013 the patient complained of toothaches, headaches, and pain radiating down to her spine. She also felt like vomiting and developed right hand and left leg tremors. She was taken to an emergency room and released after treated with ATIVAN. The patient is scheduled to see a neurologist that night. The outcome of black bruised mark on the right arm, left leg tremors, developed right hand tremors, felt like vomiting, pain radiating down to the spine, toothaches and headaches was reported as not recovered. X-ray and Blood work were performed. Additional information has been requested.
Hives.  Not swollen or itchy, but large irregular shaped red marks on upper chest and back, upper stomach and upper arms